CommaSoft
Desconocido
discovAIR: Discovering the cellular landscape of the airways and the lung
COMMA SOFT AG
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Lung diseases are a leading cause of death, with increasing incidence and lack of curative interventions. The development of novel therapeut...
2019-12-09 - 2022-06-30 | Financiado
2019-12-09 - 2022-06-30 | Financiado
SYSCID: A Systems medicine approach to chronic inflammatory disease
COMMA SOFT AG
participó en un
H2020:
H2020-SC1-2016-2017
"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indicatio...
2016-12-01 - 2022-09-30 | Financiado
2016-12-01 - 2022-09-30 | Financiado
* No se disponen de datos de la empresa actual.